AMYPAD at AD/PD2024

The next Alzheimer’s and Parkinson’s Diseases Conference (AD/PD) to be held fron 5-9 March 2024 in Lisbon (Portugal) will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.

AD/PD™ works towards advancing innovative strategies in therapy, prevention, clinical trials and diagnostic markers, in order to focus on driving successful collaborations among academia and industry, leading to the development of innovative therapies and ultimately providing a better future for patients and families affected by neurodegenerative diseases.

We are pleased that Leonard Pieperhoff, PhD candidate at the Amsterdam University Medical Centre’s Department of Radiology and Nuclear Medicine, will be presenting an oral presentation entitled “Amyloid predicts longitudinal atrophy in non-demented individuals: results from the AMYPAD Prognostic & Natural History Study” on 8 March during the symposium “Fluid Biomarkers and Imaging 02” chaired by Gil Rabinovici and Agneta Nordberg (Auditorium VI+VII). In this work, Leonard investigated the cross-sectional and longitudinal association between cortical amyloid deposition and subsequent neurodegeneration in a large cohort of people without dementia from the AMYPAD Prognostic and Natural History Study (PNHS).

You can find more information on the event such as the programme here: https://adpd.kenes.com/

AMYPAD at AD/PD2024
More News